Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,159 | -10,830 | -9,622 | -8,451 | -6,617 |
| Depreciation Amortization | 6 | 25 | 19 | 13 | 6 |
| Accounts payable and accrued liabilities | 169 | -666 | -736 | -286 | 259 |
| Other Working Capital | -28 | -731 | -953 | -345 | 1,627 |
| Other Operating Activity | -7,882 | 982 | 1,020 | 529 | -106 |
| Operating Cash Flow | $-1,575 | $-11,219 | $-10,272 | $-8,541 | $-4,830 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,500 | 2,500 | 2,500 | 2,500 |
| Debt Repayment | N/A | -2,500 | -2,500 | -2,500 | -2,500 |
| Common Stock Issued | 14,030 | 4,456 | 16,380 | 5 | 11,929 |
| Common Stock Repurchased | N/A | -7,652 | -7,652 | -7,652 | -7,652 |
| Other Financing Activity | -5 | 18,394 | 6,465 | 18,389 | 6,465 |
| Financing Cash Flow | $14,025 | $15,198 | $15,193 | $10,742 | $10,742 |
| Beginning Cash Position | 5,253 | 1,275 | 1,275 | 1,275 | 1,275 |
| End Cash Position | 17,703 | 5,253 | 6,195 | 3,476 | 7,186 |
| Net Cash Flow | $12,450 | $3,978 | $4,921 | $2,201 | $5,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,575 | -11,219 | -10,272 | -8,541 | -4,830 |
| Free Cash Flow | -1,575 | -11,219 | -10,272 | -8,541 | -4,830 |